Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-16-002967
Filing Date
2016-11-16
Accepted
2016-11-16 16:55:07
Documents
1
Period of Report
2016-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7464
  Complete submission text file 0001123292-16-002967.txt   8797
Mailing Address 351 E. EVELYN AVENUE MOUNTAIN VIEW CA 94041
Business Address 351 E. EVELYN AVENUE MOUNTAIN VIEW CA 94041 6509345200
VIVUS INC (Issuer) CIK: 0000881524 (see all company filings)

EIN.: 943136179 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELSUS THERAPEUTICS PLC 24 WEST 40TH STREET NEW YORK NY 10018
Business Address
Shaw Allan (Reporting) CIK: 0001626850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33389 | Film No.: 162002978